Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001554816 | SCV001776122 | benign | Pityriasis rubra pilaris | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554817 | SCV001776123 | benign | Psoriasis 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001685528 | SCV001898325 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV001554816 | SCV004032435 | uncertain significance | Pityriasis rubra pilaris | criteria provided, single submitter | clinical testing | CARD14 is a scaffold protein that mediates NF-κB signal transduction in skin keratinocytes. Potent mutations in Card14 have been shown to be associated with familial pustular psoriasis and other cutaneous inflammatory conditions like Pytriasis rubra pilaris. However, the role of rs4889991 is yet to be ascertained. | |
Unidad de Genómica Garrahan, |
RCV003399363 | SCV004123017 | benign | not specified | 2023-11-14 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001685528 | SCV005248782 | benign | not provided | criteria provided, single submitter | not provided |